Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Genome-wide association study of suicidal ideation emerging during citalopram treatment of depressed outpatients
Pharmacogenetics and genomics, 09/11/09
Laje G et al. – Together with the earlier report, these findings may shed light on the biological basis of TESI and may help identify patients at increased risk of this potentially serious adverse event.
Related Articles
Predictors of depression in a multiethnic cohort of patients with rheumatoid arthritis
Arthritis Care and Research, 11/03/09
Relevance Score: 95%
Survival after myocardial infarction worse with first episode major depression than recurrent major depression
Evidence-Based Mental Health, 11/02/09
Relevance Score: 95%
Quality of life and depression among metastatic breast cancer patients
Medical Oncology, 10/05/09
Relevance Score: 95%
Serious diabetes-specific emotional problems in patients with type 2 diabetes who have different levels of comorbid depression: A Polish study from the European Depression in Diabetes (EDID) Research Consortium
European Psychiatry, 11/06/09
Relevance Score: 94%
A systematic review of longitudinal studies on the association between depression and smoking in adolescents
BMC Public Health, 10/01/09
Relevance Score: 94%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Update on the management of attention-deficit/hyperactivity disorder in children and adults: patient onsiderations and the role of lisdexamfetamine
Therapeutics and Clinical Risk Management, 12/09/09
Combination of intensive cognitive rehabilitation and donepezil therapy in Alzheimer's disease (AD)
Archives of Gerontology and Geriatrics, 12/09/09
Neuroimaging to assess safety and efficacy of AD therapies
Expert Opinion on Investigational Drugs, 12/09/09
Sponsor
Article Search
Sponsor


See Latest Articles


